2020
DOI: 10.1186/s12884-020-03458-x
|View full text |Cite
|
Sign up to set email alerts
|

Accelerated fetal growth in early pregnancy and risk of preterm birth: a prospective cohort study

Abstract: Background Preterm birth (occurring before 37 completed weeks of gestation) affects 15 million infants annually, 7.5% of which die due to related complications. The detection and early diagnosis are therefore paramount in order to prevent the development of prematurity and its consequences. So far, focus has been laid on the association between reduced intrauterine fetal growth during late gestation and prematurity. The aim of the current study was to investigate the association between acceler… Show more

Help me understand this report
View preprint versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(2 citation statements)
references
References 33 publications
0
2
0
Order By: Relevance
“…Antenatal symptoms [28] occurred in almost onequarter of MVID cases, but were not different between the preterm and at term birth groups. Increased fetal growth has been shown to increase the risk of spontaneous late preterm birth [29,30]. Higher birth weight percentiles were observed in MVID patients who were born preterm, when compared to those born at term.…”
Section: Discussionmentioning
confidence: 99%
“…Antenatal symptoms [28] occurred in almost onequarter of MVID cases, but were not different between the preterm and at term birth groups. Increased fetal growth has been shown to increase the risk of spontaneous late preterm birth [29,30]. Higher birth weight percentiles were observed in MVID patients who were born preterm, when compared to those born at term.…”
Section: Discussionmentioning
confidence: 99%
“…Due to the great controversial and variety about the diagnostic criteria for GDM, there is an increasing need to establish biomarkers able to identify in early pregnancy the occurrence of GDM. Currently, the Gold Standard is made with an OGTT at around 26–28 weeks of gestation but it is known that differences in fetal growth occur even at early pregnancy (at 12 weeks) between mothers who will be diagnosed with GDM and who will be not [ 34 ]. Finding out accessible and stable biomarkers for predicting GDM would allow an early intervention and the subsequent reduction risk both in mothers and their offspring.…”
Section: Discussionmentioning
confidence: 99%